Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option
★★★★★ 3rd-party
External rating
- Source: Third-party data provider (Groww/CRISIL)
- Original rating: 2/5, displayed as-is — TopFund does not modify third-party ratings
- Refresh frequency: Whenever TopFund re-syncs this fund's data
- Limitations: The provider's own rating methodology isn't disclosed here — see the provider's own site for their criteria
TopFund Score: 67/100 · Good
How this score is calculated
- Star rating (35%)2/5
- 3Y CAGR (30%)19.95%
- Expense ratio (20%)1.06%
- AUM (15%)₹1,541 Cr
Not investment advice — an analytical read of public fund data. Methodology →
Tata Mutual Fund · Equity · Sectoral
₹39.55
AUM: ₹1,541 Cr
NAV updated 20 days ago
Plan
Regular
Option
Growth
Risk
Very High
Expense Ratio
1.06%
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Fund Manager
Rupesh Patel, Sonam Udasi
Inception
Dec 2015
Benchmark
BSE Healthcare Total Return Index
Sharpe Ratio
0.12
Std Dev (1Y)
11.97%
Historical Returns (CAGR)
Annualized trailing returns computed from NAV history — past performance only, not a guarantee of future results.
1m
-0.99%
3m
+8.03%
6m
+13.36%
1y
+10.23%
3y
+19.95%
5y
+14.76%
10y
+15.01%
since inception
+11.51%
TopFund's Take on TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option
TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option holds up reasonably well within the Sectoral category, currently carrying a 2-star rating. TopFund's composite Health Score, which weighs rating, 3-year CAGR, expense ratio and fund size, puts it at 67/100.
Cost: At 1.06%, the expense ratio is roughly in line with the Sectoral category average of 0.99% — cost isn't a standout factor either way for this fund.
Risk-adjusted performance: Over the trailing 1-year period, the fund shows a modest Sharpe ratio of 0.12 — returns have only marginally compensated for the risk taken. Separately, annualised volatility of 11.97% is on the lower side for a Sectoral fund, suggesting a comparatively smoother ride.
Who should invest: This fund is best suited to investors whose goals and risk appetite align with a Equity fund. Given the Very High risk rating, this fund is not suited to short-term goals or investors who may need to exit within 2-3 years.
This is an automated, data-driven analysis based on the fund's own metrics and its category peers — not personalized investment advice. Consult a SEBI-registered advisor before investing.
Sector Allocation
Asset Allocation
Fund Snapshot
Similar Funds
DSP Nifty Healthcare Index Fund - Direct- Growth
DSP Mutual Fund
quant BFSI Fund - Growth Option - Direct Plan
Quant Mutual Fund
DSP Nifty Bank Index Fund - Direct - Growth
DSP Mutual Fund
Invesco India Financial Services Fund - Direct Plan - Growth
Invesco Mutual Fund
BANK OF INDIA Manufacturing & Infrastructure Fund-Direct Plan-Growth
Bank of India Mutual Fund
Bandhan BSE Healthcare Index Fund Direct Plan - Growth
Bandhan Mutual Fund
Tools & Guides for This Fund
Frequently Asked Questions about TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option
The current NAV (Net Asset Value) of TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option is ₹39.55. NAV is updated every business day after market close by AMFI.
1Y: 10.23% · 3Y CAGR: 19.95% · 5Y CAGR: 14.76%
The expense ratio of TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option is 1.06% per annum. This is the annual fee charged by the fund to manage your investment.
TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option is managed by Rupesh Patel, Sonam Udasi at Tata Mutual Fund.
TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option is classified as a Very High risk fund. It is suitable for aggressive investors with a long-term horizon of 5+ years.
TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option is a Sectoral fund. SIP suitability depends on your investment goal and risk profile.
You can start a SIP in TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option with as little as ₹500 per month through most mutual fund platforms. The minimum lump sum investment is typically ₹1,000.
The Assets Under Management (AUM) of TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option is ₹1,541 crore. AUM indicates the total market value of assets managed by the fund.
* Past performance is not indicative of future results. Mutual fund investments are subject to market risks.
Discussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.